Sv Life Sciences Fund Iv Strategic Partners, L. P. - Net Worth and Insider Trading
Sv Life Sciences Fund Iv Strategic Partners, L. P. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sv Life Sciences Fund Iv Strategic Partners, L. P. owns 6 companies in total, including KalVista Pharmaceuticals Inc (KALV) , Entellus Medical Inc (ENTL) , and Ocular Therapeutix Inc (OCUL) among others .
Insider Ownership Summary of Sv Life Sciences Fund Iv Strategic Partners, L. P.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
KALV | KalVista Pharmaceuticals Inc | 2018-12-19 | 10 percent owner |
ENTL | Entellus Medical Inc | 2017-01-31 | 10 percent owner |
OCUL | Ocular Therapeutix Inc | 2014-07-24 | 10 percent owner |
2013-09-24 | 10 percent owner | ||
2013-09-03 | 10 percent owner | ||
2010-05-03 | 10 percent owner |
Sv Life Sciences Fund Iv Strategic Partners, L. P. Trading Performance
Sv Life Sciences Fund Iv Strategic Partners, L. P. Ownership Network
Sv Life Sciences Fund Iv Strategic Partners, L. P. Owned Company Details
What does KalVista Pharmaceuticals Inc do?
Who are the key executives at KalVista Pharmaceuticals Inc?
Sv Life Sciences Fund Iv Strategic Partners, L. P. is the 10 percent owner of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include Chief Medical Officer Paul K. Audhya , Chief Development Officer Christopher Yea , and CFO and Secretary Benjamin L Palleiko .
KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary
Over the past 18 months, Sv Life Sciences Fund Iv Strategic Partners, L. P. made no insider transaction in KalVista Pharmaceuticals Inc (KALV). Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,251,017 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 155,123 shares made by Benjamin L Palleiko , and a net sale of 95,977 shares made by Christopher Yea .
In summary, during the past 3 months, insiders sold 41,171 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 41,171 shares. During the past 18 months, 600,355 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,251,017 shares were bought by its insiders, resulting in a net purchase of 650,662 shares.
KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.
KalVista Pharmaceuticals Inc Insider Transactions
Sv Life Sciences Fund Iv Strategic Partners, L. P. Mailing Address
Above is the net worth, insider trading, and ownership report for Sv Life Sciences Fund Iv Strategic Partners, L. P.. You might contact Sv Life Sciences Fund Iv Strategic Partners, L. P. via mailing address: One Boston Place, 201 Washington Street, Suite 3900, Boston Ma 02108.